Projects
The pharmaceutical projects listed in this section are those that are announced from time to time around the world
Frontage Laboratories Expands Bioanalytical Capacity and Capabilities
Frontage Laboratories is expanding its bioanalytical laboratories in the US, in Exton, PA The expansion will include an additional 10,000 square feet of laboratory space to support biologic drug development, cell and gene therapy development as well as biomarker analysis
TriPharm Services to Develop Pharma Manufacturing Centre in US
TriPharm Services has announced its plans to develop a new pharmaceutical manufacturing centre in Morrisville, North Carolina, US The facility, utilising the latest isolator manufacturing equipment, will be situated at 627 Davis Drive, Morrisville and will cover an area of 32,000 square feet
QuVa Pharma Announces Pharma Facility Expansion
QuVa Pharma has announced expansion plans of its biotech pharmaceutical manufacturing facility in Bloomsbury, New Jersey
Catalent Invests US$9million in a New Clinical Supply Facility in San Diego
Catalent has invested US$9million in a new clinical supply facility in San Diego The new 24,257 squarefeet facility is expected to provide clinical supply services to clients in the early stages of clinical development
Atlas Biotechnologies Announces Expansion Plan in Europe
Atlas Biotechnologies is pleased to announce its expansion into European markets starting with Denmark The expansion includes a new medical cannabis project Atlas Growers Denmark
Cambrex to Expand Its Edinburgh Screening Facility
Cambrex corporation announced plans to expand its facility in Edinburgh, Scotland, doubling the current footprint to 15,000 square feet
Pfizer Invests US$500 million For Gene Therapy Facility Expansion
Pfizer has announced its plans to invest US$500 million to construct a stateoftheart gene therapy manufacturing facility in Sanford, North Carolina
Fujifilm Irvine Plans New Manufacturing Facility in Europe
Fujifilm Irvine Scientific announced plans to build a new manufacturing facility to accelerate the development in bioproduction, and cell and gene therapy markets in Tilburg, Netherlands
Lonza Expands its Manufacturing Capabilities at Tampa Site
Lonza announced the completion of the expansion of US$15 million multiphase solid oral dose development and manufacturing capabilities at its Tampa, FL USA site
Mapi Pharma to Build a New Sterile Injectable Production Plant in Jerusalem
Mapi Pharma has signed a long term lease agreement at the HarHotzvim HiTech Park in Jerusalem to establish a new sterile production plant for GA Depot injectable products
